Morgan Stanley analyst Craig Hettenbach recommends investing in Tenet Healthcare due to its evolving business model and growth potential. With a target price of $165, he believes the stock offers significant upside despite political uncertainties. The company's focus on outpatient care and strategic acquisitions could drive future growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing